Michael A. Nauck
Expertise in
8
conditions

Michael A. Nauck

St. Josef Hospital, 
Bochum, NW, DE 
Expertise in
8
conditions
St. Josef Hospital, 
Bochum, NW, DE 

Overview

Michael Nauck practices practicing medicine in Bochum, Germany.

Mr. Nauck is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Insulinoma.

He is actively involved in clinical research, co-authoring 190 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

St. Josef Hospital, Bochum, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Enrollment Status: Completed
Publish Date: January 30, 2017
Intervention Type: Drug, Other
Study Phase: Phase 3
View 1 Less Clinical Trial

190 Total Publications

Causes and consequences of discontinuation of GLP1RAs or tirzepatide.
Causes and consequences of discontinuation of GLP1RAs or tirzepatide.
Journal: Nature reviews. Endocrinology
Published: April 28, 2026

Frequently Asked Questions about Michael A. Nauck

Is Michael A. Nauck a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Michael A. Nauck is classified as an Elite expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael A. Nauck participate in research or clinical trials?

Yes. Michael A. Nauck has published 190 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Michael A. Nauck's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nauck's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile